Home

BKV Corporation Common Stock (BKV)

17.11
-3.26 (-16.00%)
NYSE · Last Trade: Apr 4th, 7:37 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Breaking Down BKV: 7 Analysts Share Their Viewsbenzinga.com
Via Benzinga · March 4, 2025
Earnings Scheduled For February 26, 2025benzinga.com
Via Benzinga · February 26, 2025
The Analyst Verdict: BKV In The Eyes Of 7 Expertsbenzinga.com
Via Benzinga · January 30, 2025
Where BKV Stands With Analystsbenzinga.com
Via Benzinga · January 13, 2025
Forecasting The Future: 12 Analyst Projections For BKVbenzinga.com
Via Benzinga · December 23, 2024
Insiders Bet Big on These Small Cap Stocks
Insiders are buying stocks like CalciMedica and BKV Corporation because they have value and catalysts in 2025 to drive higher share prices.
Via MarketBeat · November 14, 2024
Analyst Expectations For BKV's Futurebenzinga.com
Via Benzinga · November 13, 2024
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
BKV's Integrated Operations Offer Value, Analyst Highlights Unique 'Closed-Loop' System And Growth Prospectsbenzinga.com
Truist Securities analyst initiates Buy rating & $24 price target for BKV Corporation, owned by Banpu with potential for future equity sales.
Via Benzinga · October 25, 2024
This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga.com
Via Benzinga · October 25, 2024
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · October 21, 2024
Self-Driving Startup Pony.ai Files For U.S. IPOtalkmarkets.com
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group -- saw their stocks open for trading.
Via Talk Markets · October 20, 2024
Obesity Drug Developer BioAge Makes Nasdaq Debuttalkmarkets.com
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials.
Via Talk Markets · September 29, 2024